Author

Caroline Shi-Yan Foo

Rega Institute for Medical ResearchORCID 0000-0002-6380-4917Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:non-human primate· 1 Organism:rat· 1

Frequent Co-Authors

Johan H. NeytsiD· 2 shared Rana AbdelnabiiD· 2 shared Alex Farina· 1 shared Alison V. TurneriD· 1 shared Alistair J. HenryiD· 1 shared Andrew G. Popplewell· 1 shared ANDREZA ESTEFANY DA SILVA OLIVEIRAiD· 1 shared Annelies Van HeckeiD· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Johan H. NeytsORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintJul 18, 2023

ACE2 mimetic antibody potently neutralizes all SARS-CoV-2 variants and fully protects in XBB.1.5 challenged monkeys

Craig W. Fenwick, Priscilla Turelli, Yoan Duhoo…·Giuseppe Pantaleo

2 citations

humannon-human primate

𝕏 PostBluesky

Molecular BiologybioRxivPreprintMar 8, 2021

Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodents

Bert Schepens, Loes van Schie, Wim Nerinckx…·Xavier Saelens

The paper describes the development of a broadly neutralizing antibody, XVR011, effective against SARS-CoV-2 and its variants in animal models.

7 citations

𝕏 PostBluesky